Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 46 | 2025 | 5189 | 4.600 |
Why?
|
Anticoagulants | 16 | 2025 | 4862 | 1.910 |
Why?
|
Vitamin K | 3 | 2024 | 312 | 1.290 |
Why?
|
Frail Elderly | 6 | 2024 | 785 | 1.150 |
Why?
|
Stroke | 17 | 2025 | 9747 | 1.000 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 2770 | 0.890 |
Why?
|
Nursing Homes | 4 | 2024 | 1084 | 0.840 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2021 | 582 | 0.770 |
Why?
|
Venous Thromboembolism | 4 | 2023 | 1882 | 0.730 |
Why?
|
Warfarin | 5 | 2024 | 1494 | 0.630 |
Why?
|
Medicare | 11 | 2024 | 6823 | 0.590 |
Why?
|
Atrial Appendage | 2 | 2023 | 284 | 0.520 |
Why?
|
Cardiovascular Diseases | 8 | 2024 | 15652 | 0.500 |
Why?
|
Heart Diseases | 3 | 2024 | 2821 | 0.500 |
Why?
|
Hypotension, Orthostatic | 1 | 2017 | 257 | 0.460 |
Why?
|
Blood Proteins | 1 | 2019 | 1188 | 0.430 |
Why?
|
Administration, Oral | 5 | 2024 | 4015 | 0.430 |
Why?
|
Patient Care Management | 1 | 2016 | 303 | 0.420 |
Why?
|
Risk Factors | 28 | 2025 | 74840 | 0.420 |
Why?
|
Metabolomics | 3 | 2023 | 1668 | 0.400 |
Why?
|
Hemorrhage | 3 | 2024 | 3461 | 0.400 |
Why?
|
Aged | 37 | 2024 | 171117 | 0.370 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2080 | 0.350 |
Why?
|
Veterans | 1 | 2024 | 2664 | 0.330 |
Why?
|
Forecasting | 1 | 2019 | 2936 | 0.330 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1416 | 0.330 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1379 | 0.330 |
Why?
|
Risk Assessment | 9 | 2024 | 24282 | 0.310 |
Why?
|
Aged, 80 and over | 17 | 2024 | 59489 | 0.300 |
Why?
|
Humans | 65 | 2025 | 765968 | 0.300 |
Why?
|
Incidence | 14 | 2024 | 21480 | 0.290 |
Why?
|
Heart Failure | 7 | 2023 | 11840 | 0.290 |
Why?
|
Dementia | 1 | 2022 | 2744 | 0.290 |
Why?
|
Brain Ischemia | 2 | 2020 | 3000 | 0.280 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 2648 | 0.270 |
Why?
|
United States | 16 | 2024 | 72903 | 0.270 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12807 | 0.260 |
Why?
|
Myocardial Infarction | 2 | 2024 | 11499 | 0.260 |
Why?
|
Thrombosis | 2 | 2022 | 2949 | 0.250 |
Why?
|
Male | 38 | 2024 | 363698 | 0.250 |
Why?
|
Female | 38 | 2024 | 396112 | 0.250 |
Why?
|
Proteomics | 1 | 2019 | 3910 | 0.240 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2023 | 6 | 0.210 |
Why?
|
Cholinesterase Inhibitors | 1 | 2024 | 241 | 0.200 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8730 | 0.200 |
Why?
|
Longitudinal Studies | 9 | 2023 | 14751 | 0.200 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2024 | 1237 | 0.190 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3251 | 0.190 |
Why?
|
Drug Substitution | 1 | 2024 | 292 | 0.190 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2023 | 284 | 0.180 |
Why?
|
Pharmacoepidemiology | 1 | 2024 | 351 | 0.180 |
Why?
|
Heart Rate | 3 | 2021 | 4204 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2023 | 845 | 0.160 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2033 | 0.160 |
Why?
|
Prognosis | 8 | 2024 | 29922 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 816 | 0.160 |
Why?
|
Uncertainty | 1 | 2024 | 761 | 0.160 |
Why?
|
Sepsis | 2 | 2024 | 2606 | 0.150 |
Why?
|
Drug Interactions | 2 | 2024 | 1417 | 0.150 |
Why?
|
Stroke Volume | 3 | 2023 | 5596 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10383 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2310 | 0.140 |
Why?
|
Atrial Function | 1 | 2017 | 98 | 0.140 |
Why?
|
Treatment Outcome | 6 | 2024 | 65188 | 0.130 |
Why?
|
Age Factors | 6 | 2020 | 18380 | 0.130 |
Why?
|
Accidental Falls | 1 | 2024 | 1078 | 0.130 |
Why?
|
Comorbidity | 4 | 2024 | 10563 | 0.130 |
Why?
|
Sex Factors | 4 | 2019 | 10603 | 0.130 |
Why?
|
Aging | 1 | 2014 | 8731 | 0.120 |
Why?
|
Heart Atria | 1 | 2021 | 1363 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13462 | 0.120 |
Why?
|
Endothelium, Vascular | 2 | 2018 | 4427 | 0.120 |
Why?
|
Vasodilation | 1 | 2018 | 970 | 0.110 |
Why?
|
Drug Utilization | 1 | 2020 | 1187 | 0.110 |
Why?
|
Metabolome | 1 | 2021 | 1005 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2021 | 1456 | 0.110 |
Why?
|
Pyrazoles | 1 | 2024 | 2033 | 0.110 |
Why?
|
Middle Aged | 20 | 2023 | 223009 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 647 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1240 | 0.100 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 990 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5891 | 0.100 |
Why?
|
Hypertension | 3 | 2023 | 8626 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2136 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2023 | 81514 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1006 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2184 | 0.090 |
Why?
|
Catheter Ablation | 1 | 2025 | 2788 | 0.090 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.090 |
Why?
|
Platelet Activation | 1 | 2015 | 645 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1316 | 0.090 |
Why?
|
Proteome | 1 | 2021 | 1899 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1662 | 0.090 |
Why?
|
Time Factors | 4 | 2021 | 40065 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39193 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2027 | 0.080 |
Why?
|
Europe | 1 | 2016 | 3423 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2194 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 814 | 0.080 |
Why?
|
Genomics | 2 | 2022 | 5929 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3928 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4247 | 0.080 |
Why?
|
American Heart Association | 2 | 2024 | 1047 | 0.080 |
Why?
|
Logistic Models | 3 | 2017 | 13266 | 0.070 |
Why?
|
Electrocardiography | 1 | 2021 | 6404 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3675 | 0.070 |
Why?
|
Prospective Studies | 2 | 2024 | 54802 | 0.070 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 1736 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2022 | 12509 | 0.060 |
Why?
|
Prevalence | 3 | 2017 | 15842 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3222 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2018 | 3985 | 0.060 |
Why?
|
Germ Cells | 1 | 2008 | 647 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3413 | 0.060 |
Why?
|
Life Style | 3 | 2024 | 3926 | 0.060 |
Why?
|
Thiazides | 1 | 2023 | 19 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6599 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10070 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8501 | 0.060 |
Why?
|
Amlodipine | 1 | 2023 | 84 | 0.050 |
Why?
|
Receptors, Angiotensin | 1 | 2023 | 141 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3850 | 0.050 |
Why?
|
DNA Methylation | 1 | 2017 | 4424 | 0.050 |
Why?
|
Glycerol | 1 | 2023 | 274 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 41649 | 0.050 |
Why?
|
Massachusetts | 3 | 2021 | 8875 | 0.050 |
Why?
|
ROC Curve | 2 | 2020 | 3620 | 0.050 |
Why?
|
Eicosanoids | 1 | 2022 | 284 | 0.040 |
Why?
|
Neprilysin | 1 | 2023 | 484 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2024 | 769 | 0.040 |
Why?
|
Glutamine | 1 | 2023 | 576 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12240 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3110 | 0.040 |
Why?
|
Automation | 1 | 2020 | 585 | 0.040 |
Why?
|
Waist Circumference | 1 | 2022 | 932 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1166 | 0.040 |
Why?
|
Systems Biology | 1 | 2021 | 481 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3607 | 0.030 |
Why?
|
Blotting, Southern | 1 | 2017 | 772 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1514 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2024 | 896 | 0.030 |
Why?
|
Brachial Artery | 1 | 2018 | 375 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1061 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 460 | 0.030 |
Why?
|
Adult | 5 | 2023 | 223044 | 0.030 |
Why?
|
Gene Frequency | 1 | 2023 | 3624 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12795 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 18071 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 770 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 667 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15398 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2140 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4908 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2008 | 12768 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1749 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12056 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1562 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2020 | 4873 | 0.030 |
Why?
|
CpG Islands | 1 | 2017 | 1207 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1030 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1946 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1915 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3708 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1123 | 0.020 |
Why?
|
Health Care Costs | 1 | 2023 | 3242 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 16047 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4080 | 0.020 |
Why?
|
Action Potentials | 1 | 2017 | 1838 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4622 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4056 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1311 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2631 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2008 | 260 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.020 |
Why?
|
Models, Genetic | 1 | 2017 | 3449 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6499 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2008 | 394 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8067 | 0.010 |
Why?
|
Coronary Disease | 1 | 2019 | 5912 | 0.010 |
Why?
|
Lung | 1 | 2023 | 10033 | 0.010 |
Why?
|
Registries | 1 | 2020 | 8297 | 0.010 |
Why?
|
Spermatozoa | 1 | 2008 | 629 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9649 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13039 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8532 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18973 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9081 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 26346 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13076 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10808 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 14071 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2008 | 1874 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2008 | 1477 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11888 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26318 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15880 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3853 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8041 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5786 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6544 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168764 | 0.010 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_